Business
CB Scientific, Inc. to Convene a Special Meeting of Stockholders on Friday, January 14, 2022
CB Scientific, Inc. to Convene a Special Meeting of Stockholders on Friday, January 14, 2022.
About this update from Cardiac Biotech Solutions Inc.
[{"type":"text","content":"Agenda includes transformational matters affecting the Company's position to manage impending growthESCONDIDO, CA / ACCESSWIRE / January 4, 2022 / CB Scientific, Inc. (OTC PINK: CBSC) ("CBSC" or the "Company") announced today that the company will convene a Special Meeting of Stockholders ("Special Meeting") on Friday, January 14, 2022, at 10:00 a.m. Eastern Standard Time. The meeting venue will be 6887 East Broad Street, Columbus, Ohio 43213, however the Company urges caution to those planning to attend personally to safeguard the health of the Company stockholders and employees."As we previously disclosed, the Company will seek shareholder approval to implement a corporate name change which more accurately describes our business direction and future growth potential, relocate our corporate domicile to a state which provides superior tax laws and corporate regulations, increase the number of our authorized common shares to facilitate essential fundraising aspirations, ratify the Company's 2021 Omnibus Stock Incentive Plan which is required to recruit and retain the best possible industry talent, as well as certain other actions necessary to properly position us for a potential listing on the Nasdaq exchange at some point in the future," said Paul Danner, Chairman of CB Scientific, Inc.The Company's Board of Directors has fixed the close of business on December 23, 2021, as the record date for the determination of holders of record of the Company's common stock entitled to notice of, and to vote at, the Special Meeting. A Proxy Statement explaining each of the proposals to be considered by the stockholders of record will be dispatched today either electronically or via physical mail. If a shareholder qualifies as a designated stockholder of record but did not receive a Proxy Statement, they should send an electronic request via email to [email protected] additional new developments occur, CB Scientific, Inc. plans to make timely announcements through press releases and regulatory filings to keep its shareholders, industry participants, and the public markets informed.About CB Scientific, Inc.CB Scientific, Inc., through its domestic and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cle...